Mirtazapine 30mg Oral Dsntgrt Tabs

Manufacturer CITRON PHARMA Active Ingredient Mirtazapine Orally Disintegrating Tablets(mir TAZ a peen) Pronunciation mir TAZ a peen
WARNING: Drugs like this one have raised the chance of suicidal thoughts or actions in children and young adults. The risk may be greater in people who have had these thoughts or actions in the past. All people who take this drug need to be watched closely. Call the doctor right away if signs like depression, nervousness, restlessness, grouchiness, panic attacks, or changes in mood or actions are new or worse. Call the doctor right away if any thoughts or actions of suicide occur.This drug is not approved for use in children. Talk with the doctor. @ COMMON USES: It is used to treat depression.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Antidepressant
đŸ§Ŧ
Pharmacologic Class
Tetracyclic antidepressant; Alpha2-adrenergic antagonist
🤰
Pregnancy Category
Category C
✅
FDA Approved
Oct 1996
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Mirtazapine is a medication used to treat depression. It works by helping to restore the balance of certain natural substances in the brain. It can also help with sleep and appetite, which are often affected by depression. This specific form dissolves quickly in your mouth.
📋

How to Use This Medicine

Taking Your Medication

To take this medication correctly, follow your doctor's instructions and read all the information provided. Take your dose at bedtime if it makes you sleepy. You can take it with or without food.

When taking the tablet, do not push it out of the foil packaging. Instead, use dry hands to remove it from the foil and place it on your tongue, allowing it to dissolve. You do not need water, and do not swallow the tablet whole. Also, do not chew, break, or crush the tablet.

Only remove the medication from the blister pack when you are ready to take it, and take it immediately after opening the pack. Do not store the removed medication for later use.

Continue taking this medication as directed by your doctor or healthcare provider, even if you feel well.

Storing and Disposing of Your Medication

Store your medication at room temperature, protected from light, and in a dry place. Avoid storing it in a bathroom. Keep all medications in a safe location, out of the reach of children and pets.

When disposing of unused or expired medication, do not flush it down the toilet or pour it down the drain unless instructed to do so. Check with your pharmacist for guidance on the best disposal method. You may also have access to local drug take-back programs.

Missing a Dose

If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and resume your regular schedule. Do not take two doses at the same time or take extra doses.
💡

Lifestyle & Tips

  • Take Mirtazapine exactly as prescribed, usually once daily at bedtime due to its sedative effects.
  • Do not chew, crush, or split the orally disintegrating tablet. Place it on your tongue, allow it to dissolve, and then swallow with saliva.
  • Avoid alcohol and other CNS depressants (e.g., sedatives, opioids) as they can increase drowsiness and dizziness.
  • Be cautious when driving or operating machinery until you know how Mirtazapine affects you.
  • Report any unusual changes in mood or behavior, especially worsening depression or suicidal thoughts, to your doctor immediately.
  • Do not stop taking Mirtazapine suddenly without consulting your doctor, as this can cause withdrawal symptoms.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: 15 mg orally once daily at bedtime, may increase every 1-2 weeks. Usual effective dose is 15-45 mg/day.
Dose Range: 15 - 45 mg

Condition-Specific Dosing:

majorDepressiveDisorder: Initial: 15 mg orally once daily at bedtime. Titrate based on clinical response and tolerability, typically in increments of 15 mg/day, up to a maximum of 45 mg/day. Allow at least 1-2 weeks between dose adjustments.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established (Safety and efficacy not established for pediatric patients <18 years of age for MDD)
Adolescent: Not established (Safety and efficacy not established for pediatric patients <18 years of age for MDD, but may be used off-label with caution and close monitoring for suicidality)
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No specific adjustment needed for CrCl > 40 mL/min.
Moderate: Consider 30% dose reduction (e.g., max 30 mg/day) for CrCl 10-40 mL/min.
Severe: Consider 50% dose reduction (e.g., max 22.5 mg/day) for CrCl < 10 mL/min.
Dialysis: Not well studied; use with caution, consider significant dose reduction and monitor closely.

Hepatic Impairment:

Mild: Consider 30% dose reduction (e.g., max 30 mg/day).
Moderate: Consider 50% dose reduction (e.g., max 22.5 mg/day).
Severe: Not recommended due to lack of data and potential for increased exposure; if used, significant dose reduction and close monitoring are required.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Mirtazapine is a tetracyclic antidepressant that enhances central noradrenergic and serotonergic activity. It acts as an antagonist at central presynaptic alpha2-adrenergic autoreceptors and heteroreceptors, leading to an increase in norepinephrine and serotonin release. It is also a potent antagonist of 5-HT2 and 5-HT3 serotonin receptors, and a potent antagonist of histamine H1 receptors, which contributes to its sedative effects.
📊

Pharmacokinetics

Absorption:

Bioavailability: Approximately 50%
Tmax: Approximately 2 hours
FoodEffect: Food has a minimal effect on the rate and extent of absorption.

Distribution:

Vd: Approximately 2.5 L/kg
ProteinBinding: Approximately 85%
CnssPenetration: Yes

Elimination:

HalfLife: 20-40 hours (average 26-30 hours)
Clearance: Reduced in renal and hepatic impairment
ExcretionRoute: Renal (approximately 75%), Fecal (approximately 15%)
Unchanged: Less than 10%
âąī¸

Pharmacodynamics

OnsetOfAction: Antidepressant effects may begin within 1-2 weeks, but full therapeutic effects may take 4-6 weeks.
PeakEffect: Clinical peak effect typically seen after 4-6 weeks of consistent dosing.
DurationOfAction: Due to long half-life, once-daily dosing is sufficient to maintain therapeutic levels.

Safety & Warnings

âš ī¸

BLACK BOX WARNING

Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of Major Depressive Disorder (MDD) and other psychiatric disorders. Anyone considering the use of Mirtazapine or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber. Mirtazapine is not approved for use in pediatric patients.
âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of low sodium levels, including:
+ Headache
+ Trouble focusing
+ Memory problems
+ Feeling confused
+ Weakness
+ Seizures
+ Changes in balance
Redness or irritation of the palms of hands or soles of feet
Flu-like symptoms
Mouth irritation or mouth sores
Restlessness
Fast or abnormal heartbeat
Severe dizziness or fainting
Joint pain

Serotonin Syndrome: A Potentially Life-Threatening Condition

There is a risk of developing serotonin syndrome, a severe and potentially deadly condition, especially when taking certain other medications. If you experience any of the following symptoms, contact your doctor immediately:

Agitation
Changes in balance
Confusion
Hallucinations
Fever
Fast or abnormal heartbeat
Flushing
Muscle twitching or stiffness
Seizures
Shivering or shaking
Excessive sweating
Severe diarrhea, nausea, or vomiting
Severe headache

Severe Skin Reactions: Seek Medical Help Right Away

This medication can cause severe skin reactions, including Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and other serious reactions. These conditions can be life-threatening and may affect other organs. If you notice any of the following symptoms, seek medical attention immediately:

Red, swollen, blistered, or peeling skin
Red or irritated eyes
Sores in your mouth, throat, nose, eyes, genitals, or any areas of skin
Fever
Chills
Body aches
Shortness of breath
Swollen glands

Other Side Effects: Contact Your Doctor if Concerned

Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to contact your doctor if you're concerned about any of the following:

Feeling dizzy, sleepy, tired, or weak
Constipation
Dry mouth
Increased appetite
Weight gain
Strange or odd dreams

If you have questions about side effects or experience any other symptoms that bother you or don't go away, contact your doctor for medical advice. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Worsening depression or anxiety
  • New or worsening thoughts of self-harm or suicide
  • Panic attacks
  • Agitation, restlessness, irritability
  • Aggressive or violent behavior
  • Unusual excitement or mania
  • Severe allergic reaction (rash, itching/swelling, severe dizziness, trouble breathing)
  • Signs of serotonin syndrome (agitation, hallucinations, fever, sweating, shivering, fast heart rate, muscle stiffness/twitching, loss of coordination, nausea, vomiting, diarrhea)
  • Signs of low white blood cell count (fever, chills, sore throat, mouth sores, flu-like symptoms) - rare but serious
  • Significant or rapid weight gain
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced.
If you are currently taking or have recently taken certain medications, including:
+ Anxiety or sleep aids like alprazolam or diazepam
+ Depression or Parkinson's disease medications, such as isocarboxazid, phenelzine, tranylcypromine, selegiline, or rasagiline, within the last 14 days (as this may increase the risk of very high blood pressure)
+ Linezolid or methylene blue
* This list is not exhaustive, and it is crucial to disclose all your medications, including prescription and over-the-counter drugs, natural products, and vitamins, as well as any health problems you have.

To ensure your safety, consult with your doctor and pharmacist about all your medications and health issues to confirm that it is safe to take this medication. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. The full effects of this drug may not be apparent for several weeks.

Do not abruptly stop taking this medication without consulting your doctor, as this may increase your risk of experiencing side effects. If you need to discontinue this drug, your doctor will instruct you on how to gradually taper off the medication to minimize potential risks.

Until you are familiar with how this medication affects you, avoid driving and engaging in activities that require alertness. Certain individuals may be at a higher risk of developing eye problems while taking this drug. Your doctor may recommend an eye exam to assess your risk. Immediately contact your doctor if you experience eye pain, changes in vision, or swelling and redness in or around the eye.

Rarely, this medication has been associated with low white blood cell counts, which can increase the risk of infection. If you have a history of low white blood cell counts, inform your doctor. Be vigilant for signs of infection, such as fever, chills, or sore throat, and promptly report these symptoms to your doctor.

This medication has been linked to abnormal heart rhythms (long QT on ECG) and, in rare cases, sudden death. Discuss these risks with your doctor. Additionally, this drug may cause elevated cholesterol and triglyceride levels. Consult with your doctor about monitoring your blood work as directed.

Avoid consuming alcohol while taking this medication. Before using marijuana, cannabis products, or prescription or over-the-counter medications that may impair your reactions, consult with your doctor. If you have phenylketonuria (PKU), discuss this with your doctor, as some products contain phenylalanine.

If you are 65 years or older, exercise caution when taking this medication, as you may be more susceptible to side effects. If you are pregnant, plan to become pregnant, or are breastfeeding, discuss the potential benefits and risks to you and your baby with your doctor.
🆘

Overdose Information

Overdose Symptoms:

  • Disorientation
  • Drowsiness
  • Impaired memory
  • Tachycardia
  • Sedation
  • Hypotension (less common)
  • Respiratory depression (rare)
  • Coma (rare)

What to Do:

Seek immediate medical attention or call Poison Control (1-800-222-1222). Treatment is generally supportive and symptomatic. There is no specific antidote.

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Monoamine Oxidase Inhibitors (MAOIs) concurrently or within 14 days of discontinuing MAOIs (risk of serotonin syndrome)
🔴

Major Interactions

  • Other serotonergic drugs (e.g., SSRIs, SNRIs, triptans, tramadol, fentanyl, lithium, St. John's Wort, tryptophan) - increased risk of serotonin syndrome.
  • CNS depressants (e.g., alcohol, benzodiazepines, opioids, sedatives, hypnotics) - additive CNS depression, increased sedation.
  • Drugs that prolong QT interval (e.g., Class IA and III antiarrhythmics, some antipsychotics, macrolide antibiotics) - theoretical risk, though mirtazapine itself has low risk of QT prolongation.
🟡

Moderate Interactions

  • Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, clarithromycin, protease inhibitors) - increased mirtazapine plasma concentrations.
  • Strong CYP1A2 inhibitors (e.g., cimetidine, fluvoxamine) - increased mirtazapine plasma concentrations.
  • Strong CYP2D6 inhibitors (e.g., quinidine, fluoxetine, paroxetine) - increased mirtazapine plasma concentrations.
  • CYP3A4 inducers (e.g., carbamazepine, phenytoin, rifampin) - decreased mirtazapine plasma concentrations, reduced efficacy.
  • Warfarin - potential for minor changes in INR, monitor closely.
đŸŸĸ

Minor Interactions

  • Anticholinergic drugs - potential for additive anticholinergic effects (e.g., dry mouth, constipation).

Monitoring

đŸ”Ŧ

Baseline Monitoring

Depression severity (e.g., HAM-D, PHQ-9)

Rationale: To establish baseline and monitor treatment response.

Timing: Prior to initiation

Suicidal ideation/behavior

Rationale: Risk assessment, especially in young adults.

Timing: Prior to initiation

Weight and BMI

Rationale: Mirtazapine can cause significant weight gain.

Timing: Prior to initiation

Blood pressure and heart rate

Rationale: To assess cardiovascular status.

Timing: Prior to initiation

Liver function tests (ALT, AST, bilirubin)

Rationale: Mirtazapine is hepatically metabolized; assess baseline function.

Timing: Prior to initiation

Renal function (SCr, eGFR)

Rationale: Mirtazapine is renally excreted; assess baseline function.

Timing: Prior to initiation

📊

Routine Monitoring

Depression severity/clinical response

Frequency: Weekly for first 4-6 weeks, then monthly or as clinically indicated

Target: Reduction in symptoms, remission

Action Threshold: Lack of improvement after adequate trial, worsening symptoms

Suicidal ideation/behavior

Frequency: Weekly for first few weeks, especially in young adults, then regularly at follow-up visits

Target: Absence of ideation/behavior

Action Threshold: Emergence or worsening of suicidal thoughts/behavior

Weight and BMI

Frequency: Monthly for first few months, then every 3-6 months

Target: Stable weight or healthy BMI

Action Threshold: Significant or rapid weight gain

Adverse effects (e.g., sedation, dry mouth, constipation, dizziness)

Frequency: At each visit, especially during dose titration

Target: Tolerable side effect profile

Action Threshold: Intolerable side effects, requiring dose adjustment or discontinuation

Blood pressure and heart rate

Frequency: Periodically, as clinically indicated

Target: Within normal limits

Action Threshold: Significant changes

đŸ‘ī¸

Symptom Monitoring

  • Worsening depression
  • Suicidal thoughts or behavior
  • Unusual changes in behavior or mood (e.g., agitation, irritability, anxiety, panic attacks, insomnia, aggression, impulsivity, hypomania, mania)
  • Sedation/drowsiness
  • Increased appetite/weight gain
  • Dry mouth
  • Constipation
  • Dizziness
  • Orthostatic hypotension
  • Flu-like symptoms, sore throat, fever (rare, agranulocytosis)

Special Patient Groups

🤰

Pregnancy

Mirtazapine is Pregnancy Category C. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Limited human data suggest no increased risk of major congenital malformations, but some studies suggest a possible association with persistent pulmonary hypertension of the newborn (PPHN) when SSRIs are used late in pregnancy (though Mirtazapine is not an SSRI, caution is warranted with any antidepressant).

Trimester-Specific Risks:

First Trimester: Limited data, no clear evidence of increased major congenital malformations.
Second Trimester: Limited data.
Third Trimester: Potential for neonatal withdrawal symptoms (e.g., respiratory distress, feeding difficulties, irritability) if exposed late in the third trimester. Monitor neonate for PPHN (though less evidence than with SSRIs).
🤱

Lactation

Mirtazapine is excreted into breast milk in small amounts. The relative infant dose (RID) is generally low (estimated 1-3%). Monitor breastfed infants for sedation, poor feeding, and poor weight gain. Use with caution, weighing benefits to mother against potential risks to infant.

Infant Risk: Low to moderate risk. Monitor for sedation, irritability, poor feeding, and weight gain.
đŸ‘ļ

Pediatric Use

Safety and efficacy have not been established in pediatric patients for Major Depressive Disorder. A black box warning exists regarding increased risk of suicidality in children, adolescents, and young adults treated with antidepressants. Use is generally not recommended.

👴

Geriatric Use

Use with caution. Elderly patients may have reduced renal and/or hepatic function, leading to higher plasma concentrations and increased risk of adverse effects (e.g., sedation, dizziness, orthostatic hypotension). Consider lower starting doses and slower titration. Monitor closely for falls and cognitive impairment.

Clinical Information

💎

Clinical Pearls

  • Mirtazapine is often chosen for depression when insomnia, anxiety, or significant weight loss are prominent symptoms, due to its sedative and appetite-stimulating effects.
  • The sedative effect is more pronounced at lower doses (e.g., 7.5-15 mg) due to saturation of H1 receptors. At higher doses (30-45 mg), the noradrenergic effects become more prominent, which can counteract some of the sedation.
  • Unlike many other antidepressants, mirtazapine has a low incidence of sexual dysfunction.
  • Weight gain is a common and significant side effect, which can be beneficial for underweight patients but problematic for others.
  • Agranulocytosis is a rare but serious adverse effect; patients should be advised to report any signs of infection (fever, sore throat) immediately.
  • Orally disintegrating tablets (ODT) are useful for patients who have difficulty swallowing pills or for whom adherence might be an issue.
🔄

Alternative Therapies

  • Selective Serotonin Reuptake Inhibitors (SSRIs) e.g., escitalopram, sertraline, fluoxetine
  • Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) e.g., venlafaxine, duloxetine
  • Bupropion (NDRI)
  • Tricyclic Antidepressants (TCAs) e.g., amitriptyline, nortriptyline
  • Other atypical antidepressants e.g., vortioxetine, vilazodone
  • Electroconvulsive Therapy (ECT)
  • Transcranial Magnetic Stimulation (TMS)
  • Psychotherapy (e.g., Cognitive Behavioral Therapy)
💰

Cost & Coverage

Average Cost: Varies, typically $10-$50 per 30 tablets (generic 30mg ODT)
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (Generic)
📚

General Drug Facts

If your symptoms or health problems do not improve or worsen over time, it is essential to contact your doctor for further evaluation and guidance. To ensure safe and effective treatment, never share your medication with others or take someone else's medication.

This medication is accompanied by a Medication Guide, a patient fact sheet that provides crucial information about its use. It is essential to read this guide carefully and review it again whenever your prescription is refilled. If you have any questions or concerns about this medication, consult your doctor, pharmacist, or other healthcare provider for clarification.

In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When reporting the incident, be prepared to provide detailed information, including the name of the medication taken, the amount consumed, and the time it occurred.